摘要
用四氯化碳(CCL4)造成大鼠肝纤维化,发现钙拮抗剂Cin能明显降低大、中剂量早期治疗组和大剂量晚期治疗组肝HA含量(P<0.01);大剂量Cin使早期治疗组肝Hyp含量降低(P<0.05),晚期治疗组肝总β-NAG活性下降。实验提示,Cin在某些生化指标上反映出对肝纤维化有一定防治效果,尤其在肝纤维化的早期,应用Cin可望获得延缓或阻止肝纤维化发展的作用。
In high or median dosage,Cinnarizine significantly decreased the hepatic hyaluronic and content(P<0.01) in rats with CCL4-induced hepatic fibrosis in an early stage;in high dosage, it did so even in advanced stage.In high dosage,the same agent de creased significantly the hydroxyproline content(P<0.05) in early stage,and also the hepatic total N-acetyl-β-glucosaminidase activities (P<0.01) in advanced stage.The experiments suggested cinnarizine has preventive and therapeutic effects on hepatic of rats,especially in early stage of the disease.
出处
《上海第二医科大学学报》
CSCD
1994年第1期28-31,共4页
Acta Universitatis Medicinalis Secondae Shanghai
关键词
钙拮抗剂
脑益嗪
葡萄糖苷酶
calcium antagonist cinnarizine hjyaluronic acid hydroxyproline N-acetyl-β-glucosaminidase